Randomized Controlled Trial
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.
Crit. Care Med. 2004 Jan 1; 32 (1): 21-30.
Randomized Controlled Trial
Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial.
CMAJ. 2010 Dec 14;182(18):1971-7.
Randomized Controlled Trial
Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a...
Crit. Care Med. 2004 Jan 1;32(1):1-12.